Ocuphire Pharma Results Presentation Deck slide image

Ocuphire Pharma Results Presentation Deck

12 ZETA-1: Baseline Characteristics Study and Fellow Eye Well-Balanced Across Arms Baseline Characteristic BCVA letters in Study Eye Letters Read (mean) BCVA letters in Fellow Eye Letters Read (mean) OCT Central Subfield Thickness in Study Eye (μm) OCT Central Subfield Thickness in Fellow Eye (μm) Intraocular Pressure in Study Eye (mmHg) Systolic Blood Pressure (mmHg) (mean) Diastolic Blood Pressure (mmHg) (mean) Heart Rate (beats/min) (mean) Hemoglobin A1C (%) (mean) Body Mass Index (kg/m^2) (mean) Note: Blood markers are normal range as baselines Source: ZETA-1 Clinical Trial APX3330 n=51 81 76 270 292 15 136 82 78 8.4 31 Placebo n=52 78 77 271 286 16 139 80 76 8.3 31 Total n=103 80 (20/25 Snellen) 77 (20/32 Snellen) 271 289 15 138 81 77 8.3 31 Good Visual Acuity Fluid Below DME Definition of 320 micron (μm) Ocuphire
View entire presentation